Brainstorm Cell Therapeutics Stock Forecast

Buy candidate since Jun 16, 2026 Gain 3.90%

The Brainstorm Cell Therapeutics Inc. stock price gained 1.71% on the last trading day (Thursday, 18th Jun 2026), rising from $0.85 to $0.86. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.96% from a day low at $0.85 to a day high of $0.87. The price has risen in 7 of the last 10 days and is up by 9.01% over the past 2 weeks. Volume fell on the last day by -4 thousand shares and in total, 1 thousand shares were bought and sold for approximately $913.78 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to fall -15.18% during the next 3 months and, with a 90% probability hold a price between $0.453 and $0.733 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

BCLI Signals & Forecast

The Brainstorm Cell Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.82 and $0.733. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 30, 2026, and so far it has risen 40.00%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock

Brainstorm Cell Therapeutics Inc. finds support from accumulated volume at $0.83 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0250 between high and low, or 2.96%. For the last week the stock has had daily average volatility of 5.88%.

Our recommended stop-loss: $0.84 (-3.22%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 34 days ago.)

Trading Expectations (BCLI) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Brainstorm Cell Therapeutics Inc. to open at $0.86, and during the day (based on 14 day Average True Range), to move between $0.83 and $0.90, which gives a possible trading interval of +/-$0.0709 (+/-8.55%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 8.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.83 (4.05%) than the resistance at $0.90 (4.11%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Brainstorm Cell Therapeutics Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 3.268 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $0.86 ( 0.540%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk